BR9007904A - Processo e composicao para o tratamento de infeccao por hiv de mamiferos - Google Patents

Processo e composicao para o tratamento de infeccao por hiv de mamiferos

Info

Publication number
BR9007904A
BR9007904A BR909007904A BR9007904A BR9007904A BR 9007904 A BR9007904 A BR 9007904A BR 909007904 A BR909007904 A BR 909007904A BR 9007904 A BR9007904 A BR 9007904A BR 9007904 A BR9007904 A BR 9007904A
Authority
BR
Brazil
Prior art keywords
treatment
composition
hiv infection
mammalian
mammalian hiv
Prior art date
Application number
BR909007904A
Other languages
English (en)
Inventor
Erfle Volker
Torben Saermark
Original Assignee
Strahlen Umweltforsch Gmbh
Torben Saermark
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Strahlen Umweltforsch Gmbh, Torben Saermark filed Critical Strahlen Umweltforsch Gmbh
Publication of BR9007904A publication Critical patent/BR9007904A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR909007904A 1989-12-07 1990-12-07 Processo e composicao para o tratamento de infeccao por hiv de mamiferos BR9007904A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3940526 1989-12-07
PCT/EP1990/002127 WO1991008753A1 (en) 1989-12-07 1990-12-07 Method and composition for the treatment of mammalian hiv infection

Publications (1)

Publication Number Publication Date
BR9007904A true BR9007904A (pt) 1992-09-29

Family

ID=6395034

Family Applications (1)

Application Number Title Priority Date Filing Date
BR909007904A BR9007904A (pt) 1989-12-07 1990-12-07 Processo e composicao para o tratamento de infeccao por hiv de mamiferos

Country Status (11)

Country Link
EP (1) EP0504191B1 (pt)
JP (1) JPH075475B2 (pt)
KR (1) KR970005329B1 (pt)
AT (1) ATE110278T1 (pt)
AU (1) AU646652B2 (pt)
BR (1) BR9007904A (pt)
DE (2) DE69011870T2 (pt)
DK (1) DK0504191T3 (pt)
ES (1) ES2048137T3 (pt)
GR (1) GR930300031T1 (pt)
WO (1) WO1991008753A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770688A (en) * 1989-12-07 1998-06-23 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Method and composition for the treatment of mammalian HIV infection
DK82892D0 (da) * 1992-06-24 1992-06-24 Michael Hansen Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
AU5103996A (en) 1995-03-09 1996-10-02 Bavarian Nordic Research Institute A/S Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
AU9531698A (en) * 1997-10-15 1999-05-03 Alk A/S Composition and method for treating an encephalomyelopathic, demyelinating or autoimmune disease
WO2012093068A1 (en) * 2011-01-03 2012-07-12 F. Hoffmann-La Roche Ag A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856936A (en) * 1973-05-07 1974-12-24 Schuyler Dev Corp Composition and method for cortisol control

Also Published As

Publication number Publication date
AU646652B2 (en) 1994-03-03
DE504191T1 (de) 1993-04-08
AU6880891A (en) 1991-07-18
JPH075475B2 (ja) 1995-01-25
ATE110278T1 (de) 1994-09-15
EP0504191B1 (en) 1994-08-24
KR970005329B1 (ko) 1997-04-15
ES2048137T1 (es) 1994-03-16
DK0504191T3 (da) 1995-03-27
EP0504191A1 (en) 1992-09-23
WO1991008753A1 (en) 1991-06-27
DE69011870T2 (de) 1994-12-15
ES2048137T3 (es) 1994-10-16
JPH05504761A (ja) 1993-07-22
GR930300031T1 (en) 1993-06-07
DE69011870D1 (de) 1994-09-29

Similar Documents

Publication Publication Date Title
DE3889964D1 (de) Verfahren und Zusammensetzung zur Behandlung und Vorbeugung von Virus-Infektionen.
BR8804823A (pt) Composicao farmaceutica,processo para tratamento de hiv e prevencao de infeccao por hiv em um ser humano e processo para producao de composicao
PT80079B (pt) Processo para a preparacao de composicoes farmaceuticas anti-virus contendo 2-dietilamino-2',6'-acetoxilida (lidocaina)
DE69535758D1 (de) Lipid-analoge zur behandlung von viralen infektionen
BR0008135A (pt) Composto, métodos para tratar uma infecção por vìrus em um ser humano e para tratar uma infecção pelo vìrus da hepatite b em um ser humano, composição farmacêutica, uso de um composto, método para liberar um composto, pacote para paciente, processo para a preparação de um composto
BR8702377A (pt) Aditivo de agente de cura,composicao de adesivo curavel por inducao e processo para posicionar fixas pecas metalicas
DK538888D0 (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
BR9007904A (pt) Processo e composicao para o tratamento de infeccao por hiv de mamiferos
EP0616535A4 (en) PROCESS FOR THE TREATMENT OF VIRAL INFECTIONS.
SE7803615L (sv) Preparat for behandling av herpes zoster och andra herpesinfektioner jemte forfarande for dess framstellning
SE8605503D0 (sv) Novel medicinal use
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
AU6796287A (en) Method and composition for prophylaxis and treatment of viral infections
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
PT859613E (pt) Utilizacao de flupirtina para a profilaxia e o tratamento de doencas associadas a uma alteracao do sistema celular hematopoietico
ZA87470B (en) Method and composition for prophylaxis and treatment of viral infections
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
GR3024236T3 (en) Use of leukoregulin for the treatment of animals infected with an envelope-virus
BR9307176A (pt) Métodos para identificação de um paciente contaminado com hiv para determinar a eficácia do tratamento de um paciente humano infectado com hiv e processo para identificar os indivíduos contaminados com hiv
BR8703333A (pt) Composicao contra virus e processo de desinfeccao de um objeto
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: C07K 14/005 (2006.01), A61K 38/17 (2006.0